Unclear risk of intrapleural tissue plasminogen activator in the setting of thoracic epidural analgesia for rib fractures.

IF 2.9 3区医学 Q1 ANESTHESIOLOGY

Pain Medicine Pub Date : 2024-07-01 DOI:10.1093/pm/pnae017

Casey Kukielski, Gavin Brion, Brett Elmore, Andrew Mendelson, Lynn Kohan, Priyanka Singla

引用次数: 0

查看原文本刊更多论文

肋骨骨折胸膜硬膜外镇痛时胸膜内组织纤溶酶原激活剂的风险不明确。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pain Medicine 医学-医学：内科

CiteScore

6.50

自引率

3.20%

发文量

187

审稿时长

3 months

期刊介绍： Pain Medicine is a multi-disciplinary journal dedicated to pain clinicians, educators and researchers with an interest in pain from various medical specialties such as pain medicine, anaesthesiology, family practice, internal medicine, neurology, neurological surgery, orthopaedic spine surgery, psychiatry, and rehabilitation medicine as well as related health disciplines such as psychology, neuroscience, nursing, nurse practitioner, physical therapy, and integrative health.